Dr. Ukena is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Avenue
Gryzmish 6
Boston, MA 02215
Summary
- Dr. Jenny Ukena is a highly experienced endocrinologist based in Boston, specializing in Diabetes and Lipid Metabolism. Her academic background includes a residency in Internal Medicine at NYU Grossman School of Medicine, and a fellowship in Endocrinology, Diabetes, and Metabolism at New York Presbyterian Hospital (Cornell Campus). She received her medical degree from Tufts University School of Medicine. Dr. Ukena currently holds the position as an Endocrinologist at Beth Israel Deaconess Medical Center and also serves as the Medical Director at Ascendis Pharma. Prior to these roles, she served as an Endocrinologist at Advocate Illinois Masonic Medical Center. She has authored significant publications in her field, with a notable presence in the Journal of Bone and Mineral Research as well as The Journal of Clinical Endocrinology and Metabolism.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
- NYU Grossman School of MedicineResidency, Internal Medicine, 2012 - 2015
- Tufts University School of MedicineClass of 2012
Certifications & Licensure
- MA State Medical License 2020 - 2025
- IL State Medical License 2017 - 2020
- NY State Medical License 2014 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 29 citationsRadioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.Laura Boucai, John N. Falcone, Jenny Ukena, Catherine C. Coombs, Ahmet Zehir
The Journal of Clinical Endocrinology and Metabolism. 2018-11-01 - 17 citationsEfficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes, Dolores M Shoback
Journal of Bone and Mineral Research. 2023-01-01 - 1 citationsPalopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, Noriko Makita, Yasuo Imanishi
Advances in Therapy. 2024-06-01
Press Mentions
- This Common Hygiene Product May Have Unintended ConsequencesDecember 5th, 2018
- Treating Diabetes with a Pill?November 26th, 2018
- Did You Know Diabetes Affects These 5 Body Parts?September 21st, 2018
- Join now to see all
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: